Taurine Deficiency in the Rat and Cat: Effects on Neurotoxic and Biochemical Actions of Kainate

  • Anders Lehmann
  • Ryan J. Huxtable
  • Anders Hamberger
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 217)

Abstract

Taurine occurs at high concentration in the brain and has been suspected to be a major inhibitory transmitter. However, only a compound that fulfils all the criteria for transmitter identification can be considered to play this role. One important criterion is that the pharmacological actions of the proposed transmitter be mimicked by the endogenous substance. This, in fact, has been demonstrated for taurine only in the cerebellar cortex (16). Thus, the present state of knowledge does not support a general transmitter role for taurine. Since taurine affects so many different processes in the brain, a “neuromodulator” function has been proposed. The fact that an exogenously added agent influences a process is not necessarily relevant for its normal function. A better understanding of the physiological role for a substance may come from studies where the endogenous level of that compound has been lowered, and physiological perturbations are observed. One of the chief reasons why so little is known about taurine function is that this experimental approach is difficult. There are presently two ways to deplete endogenous taurine selectively. One is to administer the taurine uptake blocker 2-guanidinoethane sulfonate (GES) to rodents (5), and the other is to feed cats a taurine-deficient diet (21,23). The first approach is inexpensive and comparatively rapid, but involves introduction of a neuroactive agent (15) which accumulates in the brain (5,11,12) and may have side-effects. The second approach leads to a more severe taurine depletion, but it is expensive and time-consuming. In both cases the treatment has to be carried out chronically. Adaptive changes may be induced and might indeed be anticipated if taurine has an important function. One such possibly homeostatic alteration is the claimed enhancement of Na+-independent binding of taurine after GES treatment (11).

Keywords

Taurine Release Extracellular Amino Acid Taurine Deficiency Neuroactive Amino Acid Brain Dialysis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bonhaus, D.W., Pasantes-Morales, H., and Huxtable, R.J., 1985, Actions of guanidinoethane sulfonate on taurine concentration, retinal morphology and seizure threshold in the neonatal rat, Neurochem. Int. 7:263–279.PubMedCrossRefGoogle Scholar
  2. 2.
    Fariello, R.G., Golden, R.T., and McNeal, R.B., Taurine and related amino acids in seizure disorders — current controversies, In “Taurine: Biological Actions and Clinical Perspectives” (Eds. Oja, S.S., Ahtee, L., Kontro, P. and Paasonen, M.K.), Alan R. Liss, New York (1985), pp. 413–424.Google Scholar
  3. 3.
    Fariello, R.G., Golden, R.T., and Pisa, M., 1982, Homotaurine (3-aminopropane-sulfonic acid: 3-APS) protects from the convulsant and cytotoxic effects of systemically administered kainic acid, Neurology 32:241–245.PubMedCrossRefGoogle Scholar
  4. 4.
    French, E.D., Vezzani, A., Whetsell, W.O., Jr., and Schwarcz, R., 1985, Anti-excitotoxic effects of taurine in the rat hippocampus in vivo and in vitro, Epilepsia 26:506–507.Google Scholar
  5. 5.
    Huxtable, R.J., Laird, H.E., and Lippincott, S.E., 1979, The transport of taurine in the heart and the rapid depletion of tissue taurine content by guanidinoethyl sulfonate, J. Pharmacol. Exp. Ther. 211:465–471.PubMedGoogle Scholar
  6. 6.
    Iwata, H., Yamamoti, T., Kumagae, Y., and Baba, A., Further study on cysteine sulfinate-induced EEG seizures in rat. In “Sulfur Amino Acids: Biochemical and Clinical Aspects” (Eds. Kuriyama, K., Huxtable, R.J. and Iwata, H.), Alan R. Liss, New York (1983), p. 224.Google Scholar
  7. 7.
    Izumi, K., Iglsu, H., and Fukuda, T., 1975, Effect of edetate on seizure suppressing actions of taurine and GABA, Brain Research 88:576–579.PubMedCrossRefGoogle Scholar
  8. 8.
    Lehmann, A., Hagberg, H., and Hamberger, A., 1984, A role for taurine in the maintenance of homeostasis in the central nervous system during hyperexcitation? Neurosci. Lett. 52:341–346.PubMedCrossRefGoogle Scholar
  9. 9.
    Lehmann, A., Isacsson, H., and Hamberger, A., 1983, Effects of in vivo administration of kainic acid on the extracellular amino acid pool in the rabbit hippocampus, J. Neurochem. 40:1314–1320.PubMedCrossRefGoogle Scholar
  10. 10.
    Lindroth, P., Sandberg, M., and Hamberger, A., Liquid Chromatographic determination of amino acids after pre-column fluorescence derivatization. In “Neuromethods”, Vol. 3 “Amino Acids” (Eds. Boulton, A.A., Baker, G.B. and Wood, J.D.) Humana Press, Clifton, N.J. (1985), pp. 97–116.Google Scholar
  11. 11.
    Marnela, K.-M., and Kontro, P., 1984, Free amino acids and the uptake and binding of taurine in the central nervous system of rats treated with guanidinoethanesulfonate, Neuroscience 12:323–328.PubMedCrossRefGoogle Scholar
  12. 12.
    Marnela, K.-M., Kontro, P., and Oja, S.S., 1984, Effects of prolonged guanidinoethanesulfonate administration on taurine and other amino acids in rat tissues, Med. Biol. 62:3239–3244.Google Scholar
  13. 13.
    Meldrum, B.S., 1975, Epilepsy and GABA-mediated inhibition, Int. Rev. Neurobiol. 17:1–36.PubMedCrossRefGoogle Scholar
  14. 14.
    Nakagawa, K., and Huxtable, R.J., 1985, The anticonvulsive actions of two lipophilic taurine derivatives, Neurochem. Int. 7:819–824.PubMedCrossRefGoogle Scholar
  15. 15.
    Okamoto, K., and Sakai, Y., 1981, Inhibitory actions of taurocyamine, hypotaurine, homotaurine, taurine and GABA on spike discharges of Purkinje cells, and localization of sensitive sites, in guinea pig cerebellar slices, Brain Research 206:371–386.PubMedCrossRefGoogle Scholar
  16. 16.
    Okamoto, K., Kimura, H., and Sakai, Y., 1983, Evidence for taurine as an inhibitory neurotransmitter in cerebellar stellate inter-neurons: selective antagonism by TAG (6-aminomethyl-3-methyl-4H, l,2,4-benzothiadiazinel,l-dioxide), Brain Research 265:163–168.PubMedCrossRefGoogle Scholar
  17. 17.
    Olney, J.W., and Price, M.T., 1980, Neuroendocrine Interactions of excitatory and inhibitory amino acids, Brain Res. Bull. 5 (Suppl. 2):361–368.CrossRefGoogle Scholar
  18. 18.
    Olney, J.W., Price, M.T., Fuller, T.A., Labruyere, J., Sanson, L., Carpenter, M., and Mahan, K., 1986, The anti-excitotoxic effects of certain anesthetics, analgesics and sedative-hypnotics, Neurosci. Lett. 68:29–34.PubMedCrossRefGoogle Scholar
  19. 19.
    Sanberg, P.R., Staines, W., and McGeer, E.G., 1979, Chronic taurine effects on various neurochemical indices in control and kainic acid-lesioned neostriatum, Brain Research 161:367–370.PubMedCrossRefGoogle Scholar
  20. 20.
    Sanberg, M., Butcher, S.P., and Hagberg, H., 1986, Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglyceraia — in vivo dialysis of the rat hippocampus, J. Neurochem. 47:178–184.CrossRefGoogle Scholar
  21. 21.
    Schmidt, S.Y., Berson, E.L., and Hayes, K.C., 1976, Retinal degeneration in cats fed casein. I. Taurine deficiency, Invest. Ophthal. 15:47–52.PubMedGoogle Scholar
  22. 22.
    Sturman, J.A., Gargano, A.D., Messing, J.M., and Imaki, H., 1986, Feline maternal taurine deficiency. Effect on mother and offspring, J. Nutr. (in press).Google Scholar
  23. 23.
    Sturman, J.A., Rassin, D.K., Hayes, K.C., and Gaull, G.E., 1978, Taurine deficiency in the kitten: exchange and turnover of (35S) taurine in brain, retina and other tissues, J. Nutr., 108:1462–1476.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • Anders Lehmann
    • 1
  • Ryan J. Huxtable
    • 1
    • 2
  • Anders Hamberger
    • 1
  1. 1.Institute of NeurobiologyUniversity of GöteborgGöteborgSweden
  2. 2.Department of PharmacologyUniversity of ArizonaTucsonUSA

Personalised recommendations